98%
921
2 minutes
20
With the emergence of various multi-segment myopic defocus design spectacles, evaluating and verifying their myopia control effectiveness and controlling their quality and wearing safety have gradually attracted widespread attention. At present, myopia prevention and control spectacles have not been classified as medical devices directly supervised by relevant national departments in China. Multi-segment myopic defocus design spectacles, as an important intervention for retarding the progression of myopia, especially for children and adolescents, should ensure the myopia control effectiveness, safety, and adherence to standardized fitting protocols. Aiming to provide guidance and reference for healthcare institutions and practitioners, the Society of Contact Lens Safety Monitoring & Vision Health of Chinese Health Association and the Western Optometry Expert Committee of Sichuan Optometry Society, based on the current evidence-based medical research, combined with practical experience and extensive solicitation of opinions, have reached consensus opinions on the quality control, effectiveness evaluation (including long-term effectiveness), and safety evaluation of multi-segment myopic defocus design spectacles, as well as the service norms for the fitting of spectacles.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.3760/cma.j.cn112142-20241215-00583 | DOI Listing |
Cont Lens Anterior Eye
September 2025
Shaanxi Eye Hospital, Xi'an People's Hospital (Xi'an Fourth Hospital), Affiliated People's Hospital of Northwest University, Xi'an 710004, China. Electronic address:
Background: Orthokeratology (OK) lenses have become a prevalent intervention for myopia control. However, lens decentration, a frequent complication, may influence the efficacy of myopia control. The aim of this study was to systematically assess the impact of OK lens decentration on axial length growth (ALG) in Chinese myopic children through a meta-analysis.
View Article and Find Full Text PDFClin Ophthalmol
September 2025
Faculty of Biomedical Engineering, Czech Technical University in Prague, Kladno, Czech Republic.
Aim: The objective of this study was to evaluate the efficacy of DIMS (Defocus Incorporated Multiple Segments) in comparison to control group (CTRL) in a wide age group of European progressive myopes (6-26 years).
Methods: In this prospective, non-randomised observational study, 78 myopes with progression myopia to -0.25 to -8.
Vestn Oftalmol
September 2025
Azerbaijan Medical University, Baku, Azerbaijan.
Objective: This study evaluated changes in ocular parameters in patients with progressive myopia receiving 0.01% atropine.
Material And Methods: The study included 35 children (18 girls, 51.
J Inflamm Res
September 2025
Department of Optometry, School of Health and Welfare, Dongshin University, Naju, Korea.
Objective: To evaluate the therapeutic efficacy and inflammatory modulatory effects of combined 0.01% atropine eye drops and orthokeratology (OK) lenses in controlling myopia progression among adolescent patients.
Methods: This retrospective study analyzed clinical data from 90 adolescent patients (90 eyes) with myopia treated from April 2021 to June 2023.
Ophthalmic Physiol Opt
September 2025
Centre for Vision and Eye Research, Queensland University of Technology, Brisbane, Queensland, Australia.
Purpose: Few studies have comprehensively investigated the effect of low dose atropine on the binocular vision system beyond accommodative amplitude. This study examined the effect of 0.05% atropine eye drops on a range of accommodation and vergence parameters across a 10-day period.
View Article and Find Full Text PDF